Frequency and risk factors of lower limb lymphedema following lymphadenectomy in patients with gynecological malignancies

Lower limb lymphedema (LLL) is a major cause of morbidity in patients with gynecological malignancies after surgical treatment involving lymph node (LN) dissection. The aim of this study was to estimate the prevalence of LLL in such patients and detect risk factors for its occurrence. Materials and Methods: A retrospective analysis of all patients undergoing lymphadenectomy in newly-diagnosed gynecological malignancies at the University Hospital of Zurich between 2000 and 2007 was performed. Data from 313 patients were collected. Twenty patients with pre-existing edema or missing information were excluded before analysis. Time-to-LLL was estimated using the Kaplan-Meier estimate and potential risk factors were evaluated by a Cox regression model. Results: Estimated prevalence of LLL one year after surgery was 32%, increasing to 58% eight years after surgery. Median time to diagnosis of LLL was 5.2 years. The number of removed lymph nodes was significantly associated with time-to-LLL. Diagnosis of postoperative lymphocysts and local infections were accompanied by a significantly elevated risk for the development of LLL. Furthermore, time-to-LLL decreased with a higher body mass index (BMI) of the patient. In contrast, chemo- and radiotherapy, age, positive LNs, site of lymphadenectomy, and type of cancer were not observed to be associated with the occurrence of LLL. Conclusions: LLL is a frequent postoperative complication in patients undergoing lymphadenectomy for gynecological malignancies. It is thus imperative to sufficiently educate patients about the risk and symptoms of LLL prior to surgery. The data clearly show an association between time-to-LLL and number of dissected LNs, stressing the need to prospectively analyze the prevalence of LLL and carefully plan LN sampling as increasing knowledge is gained regarding the therapeutic benefit of sentinel and systemic lymphadenectomy in patients with different stages of gynecological malignancies.

Lymphedema; Gynecological malignancies; Risk factors.

[1] Ryan M., Stainton M.C., Jaconelli C., Watts S., MacKenzie P., Mansberg T.: “The Experience of Lower Limb Lymphedema for Women After Treatment for Gynecologic Cancer”. Oncol. Nurs. Forum, 2003; 30, 417.

[2] Tanaka T., Ohki N., Kojima A., Maeno Y., Miyahara Y., Sudo T. et al.: “Radiotherapy negates the effect of retroperitoneal nonclosure for prevention of lymphedema of the legs following pelvic lymphadenectomy for gynecological malignancies: an analysis from a questionnaire survey”. Int. J. Gynecol. Cancer, 2007, 17, 460.

[3] Beesley V., Janda M., Eakin E., Obermair A., Battistutta D.: “Lymphedema after gynecological cancer treatment”. Cancer 2007, 109, 2607.

[4] Ryan M, Stainton MC, Slaytor EK, Jaconelli C, Watts S, MacKenzie P. Aetiology and prevalence of lower limb lymphoedema following treatment for gynaecological cancer. Aust N Z J Obstet Gynaecol 2003; 43(2):148.

[5] Lawenda B.D., Mondry T.E., Johnstone P.A.S.: “Lymphedema: A primer on the identification and management of a chronic condition in oncologic treatment”. CA Cancer J. Clin., 2009, 59, 8.

[6] Bergmark K., Avall-Lundqvist E., Dickman P.W., Henningsohn L., Steineck G.: “Lymphedema and bladder-emptying difficulties after radical hysterectomy for early cervical cancer and among population controls”. Int. J. Gynecol. Cancer, 16, 1130.

[7] Werngren-Elgström M., Lidman D.: “Lymphoedema of the Lower Extremities After Surgery and Radiotherapy for Cancer of the Cervix”. Scand. J. Plast. Reconstr. Surg. Hand. Surg., 1994, 28, 289.

[8] Kim S., Park Y.: “Effects of complex decongestive physiotherapy on the oedema and the quality of life of lower unilateral lymphoedema following treatment for gynecological cancer”. Eur. J. Cancer Care (Engl.), 2008, 17, 463.

[9] Abu-Rustum N., Alektiar K., Iasonos A., Lev G., Sonoda Y., Aghajanian C. et al.: “The incidence of symptomatic lowerextremity lymphedema following treatment of uterine corpus malignancies: A 12-year experience at Memorial Sloan-Kettering Cancer Center”. Gynecol. Oncol., 2006, 103, 714.

[10] Füller J., Guderian D., Köhler C., Schneider A., Wendt T.G.: “Lymph edema of the lower extremities after lymphadenectomy and radiotherapy for cervical cancer”. Strahlenther. Onkol., 2008, 184, 206.

[11] Tada H., Teramukai S., Fukushima M., Sasaki H.: “Risk factors for lower limb lymphedema after lymph node dissection in patients with ovarian and uterine carcinoma”. BMC Cancer, 2009, 9, 47.

[12] Gaarenstroom K.N., Kenter G.G., Trimbos J.B., Agous I., Amant F., Peters A.A.W. et al.: “Postoperative complications after vulvectomy and inguinofemoral lymphadenectomy using separate groin incisions”. Int. J. Gynecol. Cancer, 13, 522.

[13] Halaska M.J., Novackova M., Mala I., Pluta M., Chmel R., Stankusova H. et al.: “A prospective study of postoperative lymphedema after surgery for cervical cancer”. Int. J. Gynecol. Cancer, 2010, 20, 900.

[14] Manchana T., Sirisabaya N., Lertkhachonsuk R., Worasethsin P., Khemapech N., Sittisomwong T. et al.: “Long term complications after radical hysterectomy with pelvic lymphadenectomy”. J. Med. Assoc. Thai., 2009, 92, 451.

[15] Suprasert P., Srisomboon J., Charoenkwan K., Siriaree S., Cheewakriangkrai C., Kietpeerakool C. et al.: “Twelve years experience with radical hysterectomy and pelvic lymphadenectomy in early stage cervical cancer”. J. Obstet. Gynaecol., 2010, 30, 294.

[16] Leminen A., Forss M., Paavonen J.: “Wound complications in patients with carcinoma of the vulva. Comparison between radical and modified vulvectomies”. Eur. J. Obstet. Gynecol. Reprod. Biol., 2000, 93, 193.

[17] R Development Core Team. R: A language and environment for statistical computing. Vienna, R Foundation for Statistical Computing, 2010.

[18] Terry Therneau, original Splus->R port by Thomas Lumley (2010). survival: Survival analysis, including penalised likelihood. R package version 2.36-2. Available from: URL:http://CRAN.Rproject.org/package = survival. Accessed January 12, 2010.

[19] Venables W.N., Ripley B.D. Modern applied statistics with S. 4th ed. New York: Springer; 2002. Available from: URL:http://catdir. loc.gov/catdir/enhancements/fy0812/2002022925-d.html. Accessed January 12, 2010.

[20] Carter J., Raviv L., Appollo K., Baser R.E., Iasonos A., Barakat R.R.: “A pilot study using the Gynecologic Cancer Lymphedema Questionnaire (GCLQ) as a clinical care tool to identify lower extremity lymphedema in gynecologic cancer survivors”. Gynecol. Oncol., 2010, 117, 317.

[21] Tam K.F., Lam K.W., Chan K.K., Ngan H.Y.S.: “Natural history of pelvic lymphocysts as observed by ultrasonography after bilateral pelvic lymphadenectomy”. Ultrasound Obstet. Gynecol., 2008, 32, 87.

[22] Matsuura Y., Kawagoe T., Toki N., Tanaka M., Kashimura M.: “Long-standing complications after treatment for cancer of the uterine cervix-clinical significance of medical examination at 5 years after treatment”. Int. J. Gynecol. Cancer, 16, 294.

[23] Rouzier R., Haddad B., Dubernard G., Dubois P., Paniel B.: “Inguinofemoral dissection for carcinoma of the vulva: effect of modifications of extent and technique on morbidity and survival”. J. Am. Coll. Surg., 2003, 196, 442.

[24] Oonk M., van Os M., de Bock G., de Hullu J., Ansink A., van der Zee A.: “A comparison of quality of life between vulvar cancer patients after sentinel lymph node procedure only and inguinofemoral lymphadenectomy”. Gynecol. Oncol., 2009, 113, 301.

[25] van der Zee A.G., Oonk M.H., de Hullu J.A., Ansink A.C., Vergote I., Verheijen R.H. et al.: “Sentinel node dissection is safe in the treatment of early-stage vulvar cancer”. J. Clin. Oncol., 2008, 26, 884.

[26] Moore R., Robison K., Brown A., Disilvestro P., Steinhoff M., Noto R. et al.: “Isolated sentinel lymph node dissection with conservative management in patients with squamous cell carcinoma of the vulva: A prospective trial”. Gynecol. Oncol., 2008, 109, 65.

[27] Kizer N.T., Thaker P.H., Gao F., Zighelboim I., Powell M.A., Rader J.S. et al.: “The effects of body mass index on complications and survival outcomes in patients with cervical carcinoma undergoing curative chemoradiation therapy”. Cancer, 2011, 117, 948.

[28] Soran A., D’Angelo G., Begovic M., Ardic F., Harlak A., Samuel Wieand H. et al.: “Breast cancer-related lymphedema-what are the significant predictors and how they affect the severity of lymphedema?” Breast J., 2006, 12, 536.

[29] Paskett E.D., Naughton M.J., McCoy T.P., Case L.D., Abbott J.M.: “The epidemiology of arm and hand swelling in premenopausal breast cancer survivors”. Cancer Epidemiol. Biomarkers Prev. 2007, 16, 775.